Background—There is increasing evidence that obstructive sleep apnea (OSA) is an
independent risk factor for arterial hypertension. Because there are no controlled studies …

Obstructive sleep apnea (OSA) is a very common risk factor for hypertension, and
continuous positive airway pressure (CPAP) has been widely used to treat OSA. We …

Background: Patients with obstructive sleep apnea syndrome (OSAS) are subject to an
increased cardiovascular morbidity including systemic hypertension. Little is known about …

Background Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for
arterial hypertension. Several controlled trials have investigated the effect of continuous …

Obstructive sleep apnoea (OSA) is associated with high cardiovascular morbidity and
mortality. Several randomised controlled trials have shown that continuous positive airway …

Ambulatory blood pressure (BP) was measured noninvasively (Oxford Medilog ABP) at 15-
minute intervals for 24 hours before and after 8 weeks of treatment with nasal continuous …

BACKGROUND Obstructive sleep apnea (OSA) can result in hypertension and significantly
increase cardiovascular morbidity and mortality. There are few reports on the long-term …

Background Obstructive sleep apnoea is associated with raised blood pressure. If blood
pressure can be reduced by nasal continuous positive airway pressure (nCPAP), such …

Background: A randomised controlled study was undertaken to examine the effect of nasal
continuous positive airway pressure (CPAP) on 24 hour systemic blood pressure (BP) in …

We investigated the way in which nasal continuous positive airway pressure (CPAP) affects
the circadian profiles of blood pressure (BP) and heart rate (HR) in obstructive sleep apnea …